Pierfrancesco Tassone

Created: Nov 11, 2026

•Updated: Nov 11, 2026

Public URLs (2)

Affiliations

Università degli Studi Magna Graecia di Catanzaro

1991 - Present

1991 - Present

2015 - Present

As of Oct 14, 2026 · 624 works

506 on NobleID · 38 being added

Title	Cited by	Year
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet Oncology	585	2017
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial The Lancet Oncology	561	2016
Mir-34: A New Weapon Against Cancer? Molecular Therapy — Nucleic Acids	498	2014
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma Blood	399	2009
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells British Journal of Cancer	361	2003

Creating an account is free.

For data access, contact info@nobleid.org.